1. Home
  2. SCYX vs INHD Comparison

SCYX vs INHD Comparison

Compare SCYX & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$0.66

Market Cap

24.6M

Sector

Health Care

ML Signal

HOLD

Logo Inno Holdings Inc.

INHD

Inno Holdings Inc.

HOLD

Current Price

$0.15

Market Cap

28.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCYX
INHD
Founded
1999
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.6M
28.1M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
SCYX
INHD
Price
$0.66
$0.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
563.4K
46.5M
Earning Date
11-05-2025
12-09-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,932,000.00
$2,645,845.00
Revenue This Year
$167.73
N/A
Revenue Next Year
$290.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
787.64
52 Week Low
$0.57
$0.12
52 Week High
$1.49
$19.78

Technical Indicators

Market Signals
Indicator
SCYX
INHD
Relative Strength Index (RSI) 45.86 19.47
Support Level $0.65 $0.12
Resistance Level $0.72 $3.45
Average True Range (ATR) 0.05 0.29
MACD 0.01 -0.01
Stochastic Oscillator 54.91 0.99

Price Performance

Historical Comparison
SCYX
INHD

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: